［1］SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics，2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
［2］AJANI JA,LEE J,SANO T,et al.Gastric adenocarcinoma［J］.Nat Rev Dis Primers,2017,3(1):17036.
［3］LIU Y,AO X,WANG Y,et al.Long non-coding RNA in gastric cancer:Mechanisms and clinical implications for drug resistance［J］.Front Oncol,2022,12:841411.
［4］CHEN Z,LI Y,TAN B,et al.Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer［J］.Drugs Today,2020,56(7):469-482.
［5］LIU CA,WANG MJ,CHI CW,et al.Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis［J］.Oncogene,2004,23(54):8731-8742.
［6］LIU CA,WANG MJ,CHI CW,et al.Overexpression of rho effector Rhotekin confers increased survival in gastric adenocarcinoma［J］.J Biomed Sci,2004,11(5):661-670.
［7］COLLIER FM,LOVING A,BAKER AJ,et al.RTKN2 induces NF-kappaB dependent resistance to intrinsic apoptosis in HEK cells and regulates BCL-2 genes in human CD4(+) lymphocytes［J］.J Cell Death,2009,2:9-23.
［8］SUN MY,ZHANG H,TAO J,et al.Expression and biological function of Rhotekin in gastric cancer through regulating p53 pathway［J］.Cancer Manag Res,2019,11:1069-1080.
［9］杜冬生,杨士友.左金丸及其组分黄连和吴茱萸治疗胃肠道疾病研究进展［J］.安徽医药,2007,11(8):673-675.
DU DS,YANG SY.Research progress on the treatment of gastrointestinal diseases with Zuojinwan and its components Huanglian and Wuzhuyu［J］.Anhui Medicine,2007,11(8):673-675.
［10］刘艳,孙健.左金丸调节AMPK/mTOR通路介导的自噬途径逆转胃癌耐药机制研究［J］.重庆医学,2022,51(1):6-11.
LIU Y,SUN J.Research on the reversal mechanism of gastric cancer drug resistance through Zuojinwan regulating the AMPK/mTOR pathway-mediated autophagy［J］.Chongqing Medicine,2022,51(1): 6-11.
［11］隋华,卫真真,王子元,等.左金丸调控PI3K/AKT/NF-κB信号通路对人大肠癌干细胞细胞耐药性的影响［J］.上海中医药杂志,2020,54(S1):127-131.
SUI H,WEI ZZ,WANG ZY,et al.The impact of Zuojinwan on the drug resistance of human colon cancer stem cells through regulating the PI3K/AKT/NF-κBsignaling pathway［J］.Shanghai Journal of Traditional Chinese Medicine,2020,54(S1):127-131.
［12］李赞，卫真真，王子元，等. 左金丸醇提物调控糖代谢改善结肠癌细胞西妥昔单抗抵抗的作用机制［J］.实用肿瘤杂志，2023,38(5):439-446.
LI Z,WEI ZZ,WANG ZY,et al.Mechanism of action of Zuojinwan alcohol extract in modulating glucose metabolism to improve cetuximab resistance in colon cancer cells［J］.Journal of Practical Oncology,2023,38(5):439-446.
［13］卫真真，隋华，姜宇郎,等.左金丸联合西妥昔单抗诱导KRAS突变肠癌细胞铁死亡作用研究［J］.中国临床药理学与治疗学，2023,28(2):130-137.
WEI ZZ,SUI H,JIANG YL,et al.Study on the effect of Zuojinwan combined with cetuximab in inducing iron death in KRAS-mutant intestinal cancer cells［J］.Chinese Clinical Pharmacology and Therapeutics,2023,28(2):130-137.
［14］楼江,李焕德.中药逆转肿瘤多药耐药作用机制研究进展［J］.中南药学,2011,9(10):772-774.
LOU J,LI HD.Research progress on the mechanism of traditional Chinese medicine reversing multidrug resistance in tumors［J］.Journal of Central South Pharmacy,2011,9(10):772-774.
［15］王祥财,郭蒸,黄莉,等．ERβ增加胃癌细胞氟尿嘧啶化疗敏感性的机制研究［J］.赣南医学院学报,2019,18(5):446-450.
WANG XC,GUO Z,HUANG L,et al.Mechanism study of ERβ increasing sensitivity to fluorouracil chemotherapy in gastric cancer cells［J］.Journal of Gannan Medical University,2019,18(5): 446-450.
［16］ITO H,MORISHITA R,NAGATA KI.Functions of Rhotekin,an effector of Rho GTPase,and its binding partners in mammals［J］.Int J Mol Sci,2018,19:2121.
［17］NAGATA K,ITO H,IWAMOTO I,et al.Interaction of a multi-domain adaptor protein,vinexin,with a Rho-effector,Rhotekin［J］.Med Mol Morphol,2009,42:9-15.
［18］CHANG YW,HUANG YS.Midbody localization of vinexin recruits rhotekin to facilitate cytokinetic abscission［J］.Cell Cycle,2017,16:2046-2057.
［19］ITO H,IWAMOTO I,MORISHITA R,et al.Possible role of Rho/Rhotekin signaling in mammalian septin organization［J］.Oncogene,2005,24:7064-7072.
［20］ZHOU J,ZHANG Y,QI Y,et al.MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma［J］.Oncol Rep,2017,37(2):1227-1234.
［21］ZHANG W,LIANG Z,LI J.Inhibition of rhotekin exhibits antitumor effects in lung cancer cells［J］.Oncol Rep,2016,35(5):2529-2534.
［22］LONG Y,WEI MH,LU JG,et al.Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN［J］.Biomed Pharmacother,2019,109(2019):2035-2042.
［23］KUANG Y,XU H,LU F,et al.Inhibition of microRNAlet-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer［J］.Cancer Sci,2021,112(1):231-242.
［24］KHAN SN,KHAN AU.Role of histone acetylation in cell physiology and diseases:An update［J］.Clin Chim Acta,2010,411(19-20):1401-1411.
［25］ZHU XM,LEBOEUFL M,LIU F,et al.HDAC1/2 control proliferation and survival in adult epidermis and pre-basal cell carcinoma via p16 and p53［J］.J Invest Dermatol,2022,142(1):77-87.
［26］管懋莹,徐蔚杰,李和根.左金丸现代药理研究进展［J］.中医药学报,2020,48(5):78-81.
GUAN MY,XU WJ,LI HG.Modern pharmacological research progress of Zuojin pill［J］.Chinese Journal of Traditional Chinese Medicine and Pharmacy,2020,48(5):78-81.
［27］吴秋雪,孙梦瑶,许博,等.左金丸醇提物抑制人胃癌SGC-7901细胞糖酵解的作用机制［J］.中草药,2021,52(1):145-151.
WU QX,SUN MY,XU B,et al.Mechanism of inhibition of glycolysis in human gastric cancer SGC-7901 cells by Zuojinwan ethanol extract［J］.Chinese Traditional and Herbal Drugs,2021,52(1):145-151.
［28］SHUMEI MA,DEJUAN KONG,XINXIN FU,et al.p53-induced autophagy regulates chemotherapy and radiotherapy resistance in multidrug resistance cancer cells［J］.Dose Response,2021,19(4):15593258211048046.